Trials / Completed
CompletedNCT00996788
Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- PT Otsuka Indonesia · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To study the anti free radical \& inflammatory effect and safety of Rebamipide in patients suffering of dyspepsia due to chronic gastritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rebamipide | Rebamipide 100 mg tid for 28 days |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2009-10-16
- Last updated
- 2013-05-15
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT00996788. Inclusion in this directory is not an endorsement.